Knoers, N. V. A. M., Levtchenko, E. & Bichet, D. G. In Pediatric Nephrology (eds Francesco, E. et al.) 1063–1085 (Springer International, 2022).

Arima, H. et al. Changing the name of diabetes insipidus: a position statement of the working group for renaming diabetes insipidus. J. Clin. Endocrinol. Metab. 108, 1–3 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Bockenhauer, D., Knoers, N. & Bichet, D. G. What’s in a name? That which we call diabetes does not taste sweet! Pediatr. Nephrol. 38, 937–939 (2023).

Article  PubMed  Google Scholar 

D’Alessandri-Silva, C. et al. Diagnosis, treatment, and outcomes in children with congenital nephrogenic diabetes insipidus: a pediatric nephrology research consortium study. Front. Pediatr. 7, 550 (2019).

Article  PubMed  Google Scholar 

Prosperi, F. et al. Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation. Sci. Rep. 10, 16383 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Bichet, D. G. & Bockenhauer, D. Genetic forms of nephrogenic diabetes insipidus (NDI): vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best. Pract. Res. Clin. Endocrinol. Metab. 30, 263–276 (2016).

Article  CAS  PubMed  Google Scholar 

Bockenhauer, D. & Bichet, D. G. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat. Rev. Nephrol. 11, 576–588 (2015).

Article  CAS  PubMed  Google Scholar 

Chen, Y. et al. A reporting tool for practice guidelines in health care: the RIGHT Statement. Ann. Intern. Med. 166, 128–132 (2017).

Article  PubMed  Google Scholar 

Guyatt, G. H. et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J. Clin. Epidemiol. 64, 395–400 (2011).

Article  PubMed  Google Scholar 

Management, A. A. O. P. S. C. O. Q. I. a. Classifying recommendations for clinical practice guidelines. Pediatrics 114, 874–877 (2004).

Article  Google Scholar 

Flynn, J. T. et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140, e20171904 (2017).

Article  PubMed  Google Scholar 

Wesche, D., Deen, P. M. & Knoers, N. V. Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr. Nephrol. 27, 2183–2204 (2012).

Article  PubMed  Google Scholar 

Moeller, H. B., Rittig, S. & Fenton, R. A. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr. Rev. 34, 278–301 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joshi, S. et al. Novel and recurrent variants in AVPR2 in 19 families with X-linked congenital nephrogenic diabetes insipidus. Eur. J. Pediatr. 177, 1399–1405 (2018).

Article  CAS  PubMed  Google Scholar 

Knoers, N. & Lemmink, H. Hereditary nephrogenic diabetes insipidus. in: M. P. Adam et al. (eds) GeneReviews(®) (University of Washington, Seattle Copyright © 1993–2023, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved., 1993) (2000, updated 2020).

Forssman, H. Is hereditary diabetes insipidus of nephrogenic type associated with mental deficiency? Acta Psychiatr. Neurol. Scand. 30, 577–587 (1955).

Article  CAS  PubMed  Google Scholar 

Hoekstra, J. A., van Lieburg, A. F., Monnens, L. A., Hulstijn-Dirkmaat, G. M. & Knoers, V. V. Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am. J. Med. Genet. 61, 81–88 (1996).

Article  CAS  PubMed  Google Scholar 

Bichet, D. G. Genetics in endocrinology pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus. Eur. J. Endocrinol. 183, R29–r40 (2020).

Article  CAS  PubMed  Google Scholar 

Hureaux, M. & Vargas-Poussou, R. Genetic basis of nephrogenic diabetes insipidus. Mol. Cell Endocrinol. 560, 111825 (2023).

Article  CAS  PubMed  Google Scholar 

Ishida, A. et al. Partial nephrogenic diabetes insipidus with a novel arginine vasopressin receptor 2 gene variant. Clin. Pediatr. Endocrinol. 31, 44–49 (2022).

Article  PubMed  Google Scholar 

Arthus, M. F. et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J. Am. Soc. Nephrol. 11, 1044–1054 (2000).

Article  CAS  PubMed  Google Scholar 

Moses, A. M., Sangani, G. & Miller, J. L. Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality. J. Clin. Endocrinol. Metab. 80, 1184–1186 (1995).

CAS  PubMed  Google Scholar 

van Lieburg, A. F. et al. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum. Genet. 96, 70–78 (1995).

Article  PubMed  Google Scholar 

Migeon, B. R. X inactivation, female mosaicism, and sex differences in renal diseases. J. Am. Soc. Nephrol. 19, 2052–2059 (2008).

Article  PubMed  Google Scholar 

Satoh, M., Ogikubo, S. & Yoshizawa-Ogasawara, A. Correlation between clinical phenotypes and X-inactivation patterns in six female carriers with heterozygote vasopressin type 2 receptor gene mutations. Endocr. J. 55, 277–284 (2008).

Article  CAS  PubMed  Google Scholar 

Morgenthaler, N. G., Struck, J., Alonso, C. & Bergmann, A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin. Chem. 52, 112–119 (2006).

Article  CAS  PubMed  Google Scholar 

Timper, K. et al. Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study. J. Clin. Endocrinol. Metab. 100, 2268–2274 (2015).

Article  CAS  PubMed  Google Scholar 

Fenske, W. et al. A copeptin-based approach in the diagnosis of diabetes insipidus. N. Engl. J. Med. 379, 428–439 (2018).

Article  CAS  PubMed  Google Scholar 

Christ-Crain, M. & Gaisl, O. Diabetes insipidus. Presse Med. 50, 104093 (2021).

Article  PubMed  Google Scholar 

Winzeler, B. et al. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study. Lancet 394, 587–595 (2019).

Article  CAS  PubMed  Google Scholar 

Refardt, J. et al. Arginine or hypertonic saline-stimulated copeptin to diagnose AVP deficiency. N. Engl. J. Med. 389, 1877–1887 (2023).

Article  CAS  PubMed  Google Scholar 

Vergier, J. et al. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: the copeptin approach. Arch. Pediatr. 25, 45–47 (2018).

Article  CAS  PubMed  Google Scholar 

Tuli, G., Tessaris, D., Einaudi, S., Matarazzo, P. & De Sanctis, L. Copeptin role in polyuria-polydipsia syndrome differential diagnosis and reference range in paediatric age. Clin. Endocrinol. 88, 873–879 (2018).

Article  CAS  Google Scholar 

Bitencourt, L. et al. The usefulness of copeptin for the diagnosis of nephrogenic diabetes insipidus in infancy: a case report. J. Pediatr. Endocrinol. Metab. 34, 1475–1479 (2021).

Article  PubMed  Google Scholar 

Bonnet, L. et al. Copeptin assays in children for the differential diagnosis of polyuria-polydipsia syndrome and reference levels in hospitalized children. Clin. Endocrinol. 96, 47–53 (2022).

Article  CAS  Google Scholar 

Binder, G., Weber, K., Peter, A. & Schweizer, R. Arginine-stimulated copeptin in children and adolescents. Clin. Endocrinol. 98, 548–5